Dionigi 1991.
Methods | Randomised clinical trial, Italy | |
Participants | 33 hospitalised adults with advanced gastric cancer, at nutritional risk due to major surgery Male:Female = 24:9 Mean age: 65 years Exclusion criteria: Not specified |
|
Interventions | Experimental group: parenteral or enteral hyperalimentation, or both. The total energy supply was 1.5 x BEE calculated according to the Harris‐Benedict formula: the ratio KcaYgN administered was adjusted to 130:1. (n = 7) Control group: oral alimentation as possible or peripheral fluids (n = 9) |
|
Outcomes | SH‐thymidine (3HT) | |
Study dates | Not stated | |
Notes | We contacted the author on 9th December 2015 by email: p.dionigi@smatteo.pv.it. We received no reply. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Not described |
Allocation concealment (selection bias) | Unclear risk | Not described |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Not described |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Not described |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | The number of participants with incomplete data was not reported. |
Selective reporting (reporting bias) | High risk | No protocol could be obtained and the trial did not report all‐cause mortality or serious adverse events. |
For‐profit bias | High risk | The trial was funded by Ajinomoto Co. Inc. |
Other bias | Low risk | The trial appeared to be free of other components that could put it at risk of bias. |